$418 Million is the total value of VR Adviser, LLC's 16 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALT | New | ALTIMMUNE INC | $48,195,000 | – | 4,500,000 | +100.0% | 11.54% | – |
| SURF | New | SURFACE ONCOLOGY INC | $25,439,000 | – | 3,877,895 | +100.0% | 6.09% | – |
| KROS | New | KEROS THERAPEUTICS INC | $25,218,000 | – | 672,306 | +100.0% | 6.04% | – |
| VXRT | New | VAXART INC | $24,470,000 | – | 2,765,000 | +100.0% | 5.86% | – |
| MYOV | New | MYOVANT SCIENCES LTD | $17,424,000 | – | 845,000 | +100.0% | 4.17% | – |
| NARI | New | INARI MEDICAL INC | $11,383,000 | – | 235,000 | +100.0% | 2.73% | – |
| KURA | New | KURA ONCOLOGY INC | $9,373,000 | – | 575,000 | +100.0% | 2.24% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $9,273,000 | – | 625,710 | +100.0% | 2.22% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICSspons adr | $7,827,000 | – | 781,940 | +100.0% | 1.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.